Wyoming Tech Reporter
SEE OTHER BRANDS

Your best source on science and technology news from Wyoming

Wyoming Tech Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wyoming Tech Reporter.

Press releases published on August 11, 2025

AI FILMS Online Studio beta launches with free browser editor and creator-funded referrals

AI FILMS Online Studio beta launches with free browser editor and creator-funded referrals

Browser-based AI film online studio opens beta with a free, no-watermark editor and a referral system that gives creators monthly credits LOS ANGELES, WY, UNITED STATES, August 11, 2025 /⁨EINPresswire.com⁩/ -- AI FILMS has opened the beta of AI FILMS …

CompaniesByZipcode.com Platform Launches to Address Market Positioning Challenges for Skilled Trades Professionals

CompaniesByZipcode.com Platform Launches to Address Market Positioning Challenges for Skilled Trades Professionals

Industry veteran Robert Szabo has emerged as a force in the local trades sector SHERIDAN, WY, UNITED STATES, August 11, 2025 /⁨EINPresswire.com⁩/ -- New Directory System Provides Geographic-Based Business Intelligence for Contractors and Service Providers …

John Kennedy FitzGerald Increases Ownership in Greenhawk Resources Inc. and Announces Leadership Changes

John Kennedy FitzGerald Increases Ownership in Greenhawk Resources Inc. and Announces Leadership Changes

TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Greenhawk Resources Inc. (“Greenhawk” or the "Company") (CSE: GRHK) announces John Kennedy FitzGerald (“FitzGerald”), of Toronto, Ontario announces that on Friday, August 8, 2025 he acquired in part through the …

Revive Therapeutics Announces Closing of First Tranche of Private Placement and Debt Settlement

Revive Therapeutics Announces Closing of First Tranche of Private Placement and Debt Settlement

TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing innovative therapeutics for critical medical needs, …

Swift Navigation and Taiwan Mobile Partner to Unlock Autonomy and Automation with Centimeter-Accurate Positioning

Swift Navigation and Taiwan Mobile Partner to Unlock Autonomy and Automation with Centimeter-Accurate Positioning

SAN FRANCISCO and TAIPEI, Taiwan, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Swift Navigation, the leader in centimeter-accurate positioning for vehicle autonomy, robotics, and precision logistics, and Taiwan Mobile, one of Taiwan’s leading telecommunications …

Microvast Reports Second Quarter 2025 Financial Results

Microvast Reports Second Quarter 2025 Financial Results

Record Q2 revenue of $91.3 million, up 9.2% year over year Gross margin increased from 32.5% to 34.7%, a 2.2 percentage point improvement year over year STAFFORD, Texas, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Microvast Holdings, Inc. (NASDAQ:MVST) (“Microvast” …

Draganfly Announces Second Quarter Results of 2025 with 37% Increase in YoY Product Sales

Draganfly Announces Second Quarter Results of 2025 with 37% Increase in YoY Product Sales

Vancouver, BC., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, is pleased to announce its second quarter …

Nuvectis Pharma Announces the Initiation of the Phase 1b Program for NXP900

Nuvectis Pharma Announces the Initiation of the Phase 1b Program for NXP900

The Phase 1b program is designed to evaluate the clinical activity of NXP900 as a single agent in patients with advanced solid tumors whose cancers harbor specific genetic alterations, and in combination with EGFR and ALK inhibitors in patients with NSCLC …

Serina Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights

Serina Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights

HUNTSVILLE, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company advancing its lead IND candidate, SER-252, for advanced Parkinson's disease, enabled by its proprietary POZ …

BBOT Debuts as a Publicly Traded Company Focused on RAS-Pathway Malignances with a Potential to Realize the Full Promise of KRAS and PI3K Inhibition

BBOT Debuts as a Publicly Traded Company Focused on RAS-Pathway Malignances with a Potential to Realize the Full Promise of KRAS and PI3K Inhibition

Business combination transaction with Helix Acquisition Corp. II, a special purpose acquisition company sponsored by affiliates of Cormorant Asset Management, completed on August 11, 2025  Closed concurrent $261 million private investment in public equity …

Biofrontera Inc. Appoints George Jones as Chief Commercial Officer

Biofrontera Inc. Appoints George Jones as Chief Commercial Officer

Woburn, MA, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (the “Company”), a biopharmaceutical company focused on the development and commercialization of photodynamic therapy (PDT), today announced the appointment of George Jones as …

Microchip Technology to Present at the KeyBanc Technology Leadership Forum

Microchip Technology to Present at the KeyBanc Technology Leadership Forum

CHANDLER, Ariz., Aug. 11, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that the Company will present at the Mizuho 2025 Technology …

Longeveron Announces Closing Of Up To $17.5 Million Public Offering

Longeveron Announces Closing Of Up To $17.5 Million Public Offering

MIAMI, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related …

Tonix Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Highlights

Tonix Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Highlights

FDA PDUFA goal date of August 15, 2025, for TNX‑102 SL for fibromyalgia: if approved by FDA, TNX‑102 SL would be the first new drug for fibromyalgia in more than 16 years  In June 2025, the Company was added to the Russell 3000® and Russell 2000® Indexes …

3D Systems Reports Second Quarter 2025 Financial Results

3D Systems Reports Second Quarter 2025 Financial Results

ROCK HILL, S.C., Aug. 11, 2025 (GLOBE NEWSWIRE) -- 3D Systems Corporation (NYSE:DDD) announced today its financial results for the second quarter ended June 30, 2025. Revenue of $95 million led by double-digit growth in Medical Technology and Aerospace …

Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update

Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update

Received clearance to proceed with pivotal trial of amezalpat combination therapy for first-line hepatocellular carcinoma (HCC) in China Granted orphan drug designation from the European Medicines Agency (EMA) for amezalpat for the treatment of patients …

Life360 Reports Record Q2 2025 Results

Life360 Reports Record Q2 2025 Results

Monthly Active Users Reached Approximately 88.0 million; Up 25% Year-Over-Year Record Q2 Global Net Additions of 136 thousand Paying Circles, Reaching 2.5 million Total Total Quarterly Revenue Increased 36% Year-Over-Year to $115.4 million Annualized …

PubMatic Announces Second Quarter 2025 Financial Results

PubMatic Announces Second Quarter 2025 Financial Results

Delivered revenue and adjusted EBITDA ahead of guidance; Revenue from omnichannel video, including CTV, grew 34% year-over-year and was 41% of total revenue; CTV revenue grew over 50% year-over-year; Supply Path Optimization represented 55%+ of total …

Crinetics Pharmaceuticals Announces August 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics Pharmaceuticals Announces August 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on August 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of …

IMDX Reports Q2 2025 Results and Momentum Toward GraftAssureDx Launch

IMDX Reports Q2 2025 Results and Momentum Toward GraftAssureDx Launch

Reiterating timelines for FDA submission in 2025 Transplant clinical trial has attracted leading transplant hospitals Booked first revenue from first-generation GraftAssureIQ research-use-only kits; began shipping second generation kits in June NASHVILLE, …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions